Key research & article

Last updated: 2025 Jun 18

Total hit(s): 16095

S.No.
1	40376714	Efficacy, immunogenicity, and safety of heterologous boosting with a novel chimera Chinese mRNA (RQ3013) SARS-CoV-2 vaccine: A randomized, double-blind, active-controlled trial.	Hum Vaccin Immunother	2025 Dec	4.7	1
2	40371698	Natural product sennoside B disrupts liquid-liquid phase separation of SARS-CoV-2 nucleocapsid protein by inhibiting its RNA-binding activity.	J Enzyme Inhib Med Chem	2025 Dec	8.6	1
3	40338231	Assessing vaccine coverage and delivery strategies for influenza and COVID-19 among Italian healthcare workers: A 2015-2023 case study.	Hum Vaccin Immunother	2025 Dec	4.7	1
4	40643200	Willingness among adults in the United States to receive a combination influenza and COVID-19 vaccine.	Hum Vaccin Immunother	2025 Dec	4.7	1
5	40530661	Immune response to and virological profile of SARS-CoV-2 before and after symptom onset in individuals vaccinated with inactivated COVID-19 vaccines.	Hum Vaccin Immunother	2025 Dec	4.7	1
6	40214651	From Wuhan to Omicron K.P2 strain: A comprehensive review of SARS-CoV-2 phylogeny and public health implications of the latest booster vaccine.	Hum Vaccin Immunother	2025 Dec	4.7	1
7	40134119	Gaps in vaccine clinical trials in Africa: A mixed scoping review and bibliometric analysis before, during, and post- COVID-19 pandemic.	Hum Vaccin Immunother	2025 Dec	4.7	1
8	40637161	Vaccine hesitancy and economic hardship: A latent class analysis of racial and ethnic minority communities at high risk of COVID-19 infection in Southern California.	Hum Vaccin Immunother	2025 Dec	4.7	1
9	40546058	Participant motivators and perceptions of risks and benefits in adult Phase 2/3 COVID-19 vaccine clinical trials.	Hum Vaccin Immunother	2025 Dec	4.7	1
10	40195167	Safety profile of self-amplifying mRNA SARS-CoV-2 vaccine ARCT-154 in adults: a pooled phase 1/2/3 randomized clinical study.	Expert Rev Vaccines	2025 Dec	4.37	1
11	40411306	Antibody-dependent enhancement of SARS-CoV-2, the impact of variants and vaccination.	Hum Vaccin Immunother	2025 Dec	4.7	1
12	40580117	Impact of the COVID-19 pandemic on lung cancer screening utilization and outcome: a health examination center retrospective study.	Ann Med	2025 Dec	3.01	1
13	40366666	A four-week study on the toxicity of repeated intramuscular administration of plant-based BA-CoV2-0301 vaccine against SARS-CoV-2 in Sprague-Dawley rats.	J Immunotoxicol	2025 Dec		1
14	40382672	The double burden of stressful life events among professional nurses: public mass shootings during the COVID-19 pandemic.	Int J Qual Stud Health Well-being	2025 Dec		1
15	40407705	T-cell responses to highly conserved SARS-CoV-2 epitopes in Hispanic Americans receiving an mRNA COVID-19 vaccine.	Hum Vaccin Immunother	2025 Dec	4.7	1
16	40546248	Impact of Stress Hyperglycemia in a Cohort of Brazilian Patients With COVID-19.	Am J Med Open	2025 Dec		1
17	40156199	COVID-19 vaccine hesitancy in Chinese residents: A national cross-sectional survey in the community setting.	Hum Vaccin Immunother	2025 Dec	4.7	1
18	40152750	Long-term alveolar-capillary diffusion impairments after severe SARS-CoV-2 pneumonia.	Ann Med	2025 Dec	3.01	1
19	40613499	A pan-beta-coronavirus vaccine bearing conserved and asymptomatic B- and T-cell epitopes protects against highly pathogenic Delta and highly transmissible Omicron SARS-CoV-2 variants.	Hum Vaccin Immunother	2025 Dec	4.7	1
20	40382340	Increased dialysis symptom index burden in maintenance hemodialysis patients during the COVID-19 lockdown period.	Ann Med	2025 Dec	3.01	1
21	40358138	Detection of S1 spike protein in CD16+ monocytes up to 245 days in SARS-CoV-2-negative post-COVID-19 vaccine syndrome (PCVS) individuals.	Hum Vaccin Immunother	2025 Dec	4.7	1
22	40555671	Adverse reactions following first three doses of the BNT162b2 mRNA COVID-19 vaccine: A prospective cohort study on relationships with individual characteristics and previous experience of adverse reactions.	Hum Vaccin Immunother	2025 Dec	4.7	1
23	40032512	Involvement of oxidative stress in post-acute sequelae of COVID-19: clinical implications.	Redox Rep	2025 Dec		1
24	40381203	Safety and immunogenicity of SARS-CoV-2 protein subunit recombinant vaccine (Indovac(R)) in healthy populations aged 18 years and above in Indonesia: A phase I, observer-blind, randomized, controlled study.	Hum Vaccin Immunother	2025 Dec	4.7	1
25	40179339	Attitudes and beliefs regarding COVID-19 and COVID-19 Omicron booster vaccine among adults in the vaccine safety datalink, 2022-2023.	Hum Vaccin Immunother	2025 Dec	4.7	1